Nidus Pharma Private Limited, a active private limited company, was established on 26 April 2004 in Chandigarh, Chandigarh, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U24239CH2004PTC041578. Registered under ROC Roc Chandigarh. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.49 M.
It upholds a compliant status. Employing 5 professional, Its leadership includes Sanjay Bansal (Director), Alka Bansal (Director), Prakhar Bansal (Director). Past directors included Nisha Gupta, Rajneesh Kumar Bansal, Alka Bansal. It holds ₹9.14 Cr open charges and ₹4.85 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Nidus Pharma Private Limited Scf-333,Second Floor,Moter Market,Monay, Mazara,, Chandigarh, Chandigarh, 160101.
U24239CH2004PTC041578
041578
26 April 2004
₹1.00 M
₹0.49 M
Roc Chandigarh
Unlisted
Active
Explore comprehensive insights into Nidus Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sanjay Bansal | Director | 10 Mar 2015 | Current |
| Alka Bansal | Director | 03 Oct 2025 | Current |
| Prakhar Bansal | Director | 03 Oct 2025 | Current |
| Krati Bansal | Director | 03 Oct 2025 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 08 Jun 2011 | Past |
| Pramod Abcsdd | Director | 17 Feb 2025 | Past |
| Pramod Abcsdd | Director | 11 Mar 2015 | Past |
| Pramod Abcsdd | Director | - | Past |
| Pramod Abcsdd | Director | - | Past |
| Pramod Abcsdd | Director | - | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Nidus Pharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 21.81% increase. The company also saw a substantial fall in profitability, with a 12.75% decrease in profit. The company's net worth moved up by a moderate rise of 8.21%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Nidus Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹91,375,000.00
₹48,500,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 23 Jun 2025 | Axis Bank Limited | ₹9.00 Cr | Open |
| 06 Sep 2023 | Others | ₹1.38 M | Open |
| 20 Jul 2023 | Axis Bank Limited | ₹1.40 Cr | Satisfied |
| 13 Dec 2019 | Others | ₹2.00 Cr | Satisfied |
| 16 Jun 2016 | Others | ₹8.00 M | Satisfied |
Explore comprehensive loan charge details -
Nidus Pharma has a workforce of 5 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Nidus Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nidus Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Alka Bansal was appointed as a Director was appointed as a Director on 03 Oct 2025 & has been associated with this company since 2 months 21 days . was completed.
Progress on Prakhar Bansal was appointed as a Director was appointed as a Director on 03 Oct 2025 & has been associated with this company since 2 months 21 days . was documented.
Krati Bansal was appointed as a Director was appointed as a Director on 03 Oct 2025 & has been associated with this company since 2 months 21 days . was recorded as a recent event.
The activity A charge registered on 20 Jul 2023 via Charge ID 100777694 with Axis Bank Limited was fully satisfied on 05 Aug 2025. was completed.
The activity A charge with Axis Bank Limited amounted to Rs. 90.00 M with Charge ID 101133091 was registered on 23 Jun 2025. was completed.
Nidus Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
The CIN of Nidus Pharma Private Limited is U24239CH2004PTC041578.
Nidus Pharma Private Limited is headquartered at Nidus Pharma Private Limited Scf-333,Second Floor,Moter Market,Monay, Mazara,, Chandigarh, Chandigarh, 160101.
Nidus Pharma Private Limited was incorporated on 26 April 2004.
The current directors of Nidus Pharma Private Limited are
The primary industry of Nidus Pharma Private Limited is Trade.
Nidus Pharma Private Limited is unlisted.
The authorized capital of Nidus Pharma Private Limited is ₹1.00 M, and the paid-up capital is ₹0.49 M.
The compliance status of Nidus Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX